Clinical Trial Update: Pharmacokinetics and Metabolic Activation of Capecitabine [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the pharmacokinetics and metabolic activation of capecitabine in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED